On Thursday, it was reported that Novavax (NASDAQ:NVAX)'s updated version of the vaccine is still under review by the U.S. Food and Drug Administration (FDA), while updated vaccines from...
Updated Covid boosters from Pfizer and Moderna will soon be administered at pharmacies, and many other locations across the U.S.
CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.
The U.S. Food and Drug Administration on Monday approved and authorized updated COVID-19 vaccines by Moderna Inc (NASDAQ: MRNA) and partners Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ:...
Investing.com -- U.S. futures traded marginally lower Wednesday, as higher oil prices and weak global economic data weighed on sentiment. Here are some of the biggest premarket U.S. stock...
President Biden announced on Friday his intention to seek further funding from Congress to support the development of a new COVID-19 vaccine. He indicated that he might request a universal...
The updated Covid vaccines from Pfizer, Moderna and Novavax still need green lights from the FDA and the CDC before they roll out to the public.
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID...
The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.
Thursday's top analyst upgrades and downgrades included Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, International Flavors & Fragrances, LivePerson, Novavax, Nvidia,...
An analyst from B.Riley upgraded Novavax (NASDAQ: NVAX) from 'neutral' to 'buy' with a price target of $15.00. Prior to this rating, Novavax had 2 buy ratings, 2 hold ratings, and 2 sell...
Shares of Novavax Inc (NASDAQ: NVAX) after reported Q2 revenue of $424 million, compared to $186 million a year ago, beating the consensus of $257.62 million. The company is on track with...
Investing.com -- Shares in Novavax (NASDAQ:NVAX) rose in premarket U.S. trading Tuesday after the vaccine maker posted an unexpected profit in the second quarter. The Maryland-based...
Novavax (NASDAQ:NVAX) disclosed:Item 1.01 Entry into a Material Definitive Agreement. Settlement Agreement On August 8, 2023, Novavax, Inc. (the “Company”) and SK bioscience Co., Ltd....
Investing.com - Novavax (NASDAQ: NVAX) reported second quarter EPS of $0.58, $2.10 better than the analyst estimate of $-1.52. Revenue for the quarter came in at $424.43M versus the...
Investing.com -- The Dow closed higher Monday, rebounding from a slip last week as investors awaited key economic data due later this week expected to show a slowdown in inflation ahead of...
Investing.com -- The S&P 500 inched higher Monday ahead of inflation data this week that will play a role in the Federal Reserve’s thinking on monetary policy later this month. The...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has been granted full Marketing Authorization (MA) by the...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, participated in today's U.S. Food and Drug Administration...
Novavax , Inc. (Nasdaq: NASDAQ:NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Singapore Health Sciences...
An analyst from H.C. Wainwright maintained Novavax (NASDAQ: NVAX) at '' 'buy' and a price target of $35.00 from a prior price target of %currency%%price%. Prior to this rating, Novavax had...
Novavax (NVAX) Extends Gain, Now Up 47%Earlier Novavax rises 7% on strong guidance, plans to cut 25%...
Investing.com -- Stocks in focus in premarket trade on Monday, May 9th. Please refresh for updates. Palantir (NYSE:PLTR) stock rose 15.6% after the data analytics software maker said it...
Novavax (NASDAQ:NVAX) shares traded 6.5% higher in pre-market Tuesday after the pharma company announced a major restructuring process that is aimed at cutting costs. Novavax said it...
Investing.com - Novavax (NASDAQ: NVAX) reported first quarter EPS of $-3.41, better than the analyst estimate of $-3.42. Revenue for the quarter came in at $81M versus the consensus estimate...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its COVID-Influenza Combination...
By Senad Karaahmetovic TD Cowen analysts downgraded Novavax (NASDAQ:NVAX) stock to Market Perform from Outperform, citing “significant uncertainties about the pending Gavi arbitration &...
A TD Cowen analyst downgraded Novavax (NASDAQ: NVAX) from Outperform to Market Perform with a price target of $10.00 from a prior price target of %currency%%price%. Prior to this rating,...
Novavax (NASDAQ:NVAX) confirms that it maintains banking relationships with several large financial institutions and that it does not hold any deposits or securities or maintain any...
On February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax (NASDAQ:NVAX) of his decision to retire as President, Research and Development, effective as of March 31, 2023. The...
By Liz Moyer Investing.com -- Stocks edged lower on Wednesday to start a new month after ending lower for February. Here are the midday movers for March 1. Novavax Inc (NASDAQ:NVAX)...
By Liz Moyer Investing.com -- U.S stocks are wobbling to start a new month after ending February on a down note. At 9:51 ET (14:51 GMT), the Dow Jones Industrial Average was up 60 points or...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, March 1st. Please refresh for updates. Kohl's (NYSE:KSS) stock fell 7.3% after the department store chain...
By Scott Kanowsky Investing.com -- Shares in Novavax Inc (NASDAQ:NVAX) shed over a fourth of their value in pre-market U.S. trading on Wednesday after the COVID-19 vaccine maker warned...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your free 7-day...
Novavax (NVAX) has filed mixed shelf of:Common StockPreferred StockDebt SecuritiesWarrantsUnits
By Oliver Gray Investing.com - Dow futures were trading slightly lower during Tuesday's evening trade, after major indices closed out the month of February with significant losses, while...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
